empty

Clinical

Antihypertensives prevent CVD even when BP normal

Antihypertensives can prevent serious cardiovascular disease (CVD) even among adults with normal blood pressure, new research suggests. 

Lung health taskforce asks public to share data

The Taskforce for Lung Health is aiming to raise awareness of the launch of its Lung Health Data Tracker.

NICE recommends new drug for relapsing MS

NICE has recommended the use of auto-injectable MS drug ofatumumab on the NHS. 

More people could benefit from antihypertensives, study finds

Many more people could benefit from blood pressure-lowering medication, according to a new study in the Lancet.

Lack of sleep increases dementia risk by 30 per cent

People who continuously sleep for six hours or less a night are roughly 30 per cent more likely to develop dementia.

'Urgent need' for evidence on discontinuing antidepressants

There is an “urgent need” for better evidence on the safest and most effective ways to discontinue antidepressants, a review finds. 

Asthma drug shortens at-home recovery from Covid-19

Early treatment with inhaled budesonide shortens recovery time among Covid-19 patients being treated in the community, PRINCIPLE has shown. 

MHRA approves self-inject treatment for relapsing MS

The MHRA has approved ofatumumab for adult patients with relapsing forms of multiple sclerosis (RMS), manufacturer Novartis has announced. 

New NICE guidance on chronic pain

People with chronic primary pain should be offered a range of treatments to help them manage their condition, says NICE in a new guideline.

Asthma exacerbation rates fall during pandemic

Fewer people with severe asthma attacks were admitted to hospital or seen by their GP during the Covid-19 pandemic.

Swallowable sponge could reduce need for endoscopies

In trials just one in 30 of the patients offered the Cytosponge were referred for an endoscopy.

Vaccine side effects generally mild, MHRA confirms

Most reports relate to injection site reactions and generalised symptoms reflecting a normal immune response to the vaccine.

Vaccines 'highly effective' in reducing severe Covid-19 in older adults

First dose protection ranged between 57-61 per cent for Pfizer vaccine and between 60-73 per cent for the Oxford-AZ vaccine (ChAdOx1)

GPhC makes U-turn on overseas exam candidates

The GPhC has caved in to demands to allow overseas registration assessment candidates to sit the exam online irrespective of time differences. 

Confusion over GPhC’s 60% exam pass rate ‘estimate’

GPhC says its “estimate” of a 60 per cent pass rate in the upcoming registration exam is “definitely not a prediction”. 

Possible link between Covid and psychiatric disorders

As many as one in eight who have had Covid-19 may be diagnosed with a psychiatric or neurological condition for the first time within six months.

Moderna vaccine not suitable for pregnant women warns WHO

The World Heath Organisation warns that pregnant women should not take Moderna's Covid vaccine.

Opioid prescribing varies widely across England

Opioid prescribing varies considerably across England and is especially marked in areas of high socio-economic deprivation, a study shows. 

Fatigue, insomnia and anxiety are long term consequences of Covid-19

Study in The Lancet looks at Covid patients six months after discharge.

Experimental RSV drug ‘promising’ says MHRA

The MHRA has granted a ‘promising innovative medicine’ designation to experimental RSV drug nirsevimab. 

Previous 1 2 3 4 5 ... 9 Next


This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.